Mapping Pulmonary and Systemic Inflammation in Preschool Aged Children With Cystic Fibrosis

Shivanthan Shanthikumar1,2,3, Sarath C Ranganathan1,2,3, Richard Saffery1,2

  • 1Infection and Immunity Theme, Murdoch Children's Research Institute, Parkville, VIC, Australia.

Frontiers in Immunology
|November 1, 2021
PubMed

Insights

Children with cystic fibrosis (CF) exhibit distinct pulmonary immune cell profiles and elevated inflammatory markers in their airways. This study reveals key differences in the immune landscape of pediatric CF lungs compared to healthy controls.

Area of Science:

  • Pediatric Immunology
  • Respiratory Medicine
  • Inflammation Research

Background:

  • The immune system in children's respiratory tracts is not well understood.
  • Mechanisms behind common childhood respiratory diseases like cystic fibrosis (CF) are unclear.

Purpose of the Study:

  • To characterize the local and systemic immune response in preschool children with CF.
  • To compare immune profiles in CF patients versus age-matched healthy children.

Main Methods:

  • Utilized high-parameter flow cytometry and inflammatory cytokine profiling.
  • Analyzed bronchoalveolar lavage (BAL) fluid and whole blood samples.
  • Employed advanced analytical pipelines for immune profiling.

Main Results:

  • Children with CF showed increased pulmonary granulocytes (CD66b+) and elevated BAL cytokines (MIP-1α, MIG, MCP-1, IL-8, IL-6).
  • Systemic neutrophils correlated positively with age in CF, while T and B cells correlated inversely.
  • Inflammatory cells in BAL exhibited higher activation/migration markers than systemic cells in both groups.

Conclusions:

  • Multiplex immune profiling effectively maps childhood lung disease mechanisms.
  • Identified specific immune signatures associated with pediatric cystic fibrosis.
  • Highlighted differences in local versus systemic immune cell activation.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
247
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
414
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.3K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
688
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.3K